Literature DB >> 30270492

Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.

Alessandro Mussa1,2, Kelly A Duffy3, Diana Carli2, Giovanni Battista Ferrero2, Jennifer M Kalish3,4.   

Abstract

Patients with Beckwith-Wiedemann spectrum (BWSp) undergo quarterly alpha-fetoprotein measurement for hepatoblastoma (HB) screening up to 4 years of age, paralleling the epidemiology of nonsyndromic HB. However, specific data on the timing of HB development in BWSp are lacking. Here we compare the timing of presentation of HBs in BWSp with a control cohort of consecutive HB cases, demonstrating that halving screening duration of screening procedures in BWSp likely will not impact its effectiveness.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Beckwith-Wiedemann; alpha-fetoprotein; cancer screening; hepatoblastoma

Mesh：

Substances：

Year:  2018        PMID： 30270492      PMCID： PMC7955797          DOI： 10.1002/pbc.27492

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  31 in total

Review 1.  The epidemiology of hepatoblastoma.

Authors:  Logan G Spector; Jill Birch
Journal:  Pediatr Blood Cancer       Date:  2012-06-12       Impact factor: 3.167

2.  Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy.

Authors:  Jennifer M Kalish; Laura K Conlin; Tricia R Bhatti; Holly A Dubbs; Mary Catherine Harris; Kosuke Izumi; Sogol Mostoufi-Moab; Surabhi Mulchandani; Sulagna Saitta; Lisa J States; Daniel T Swarr; Alisha B Wilkens; Elaine H Zackai; Kristin Zelley; Marisa S Bartolomei; Kim E Nichols; Andrew A Palladino; Nancy B Spinner; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2013-06-26       Impact factor: 2.802

Review 3.  Management of hepatoblastoma: an update.

Authors:  Nathalie Kremer; Ashley E Walther; Gregory M Tiao
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

4.  Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Giovanni Battista Ferrero
Journal:  Am J Med Genet A       Date:  2017-03       Impact factor: 2.802

Review 5.  Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?

Authors:  Angela D Trobaugh-Lotrario; Rajkumar Venkatramani; James H Feusner
Journal:  J Pediatr Hematol Oncol       Date:  2014-07       Impact factor: 1.289

6.  (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Silvia Russo; Agostina De Crescenzo; Andrea Freschi; Luciano Calzari; Silvia Maitz; Marina Macchiaiolo; Cristina Molinatto; Giuseppina Baldassarre; Milena Mariani; Luigi Tarani; Maria Francesca Bedeschi; Donatella Milani; Daniela Melis; Andrea Bartuli; Maria Vittoria Cubellis; Angelo Selicorni; Margherita Cirillo Silengo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

Review 7.  (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome: a paradigm for genomic medicine.

Authors:  A Mussa; S Russo; L Larizza; A Riccio; G B Ferrero
Journal:  Clin Genet       Date:  2015-07-30       Impact factor: 4.438

8.  Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol.

Authors:  Yuri A Zarate; Rafael Mena; Lisa J Martin; Paul Steele; Bradley T Tinkle; Robert J Hopkin
Journal:  Am J Med Genet A       Date:  2009-08       Impact factor: 2.802

9.  Prevalence of Beckwith-Wiedemann syndrome in North West of Italy.

Authors:  Alessandro Mussa; Silvia Russo; Agostina De Crescenzo; Nicoletta Chiesa; Cristina Molinatto; Angelo Selicorni; Lorenzo Richiardi; Lidia Larizza; Margherita Cirillo Silengo; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

10.  Genomic profiles of a hepatoblastoma from a patient with Beckwith-Wiedemann syndrome with uniparental disomy on chromosome 11p15 and germline mutation of APC and PALB2.

Authors:  Shinn Young Kim; Seung-Hyun Jung; Min Sung Kim; Mi-Ryung Han; Hyeon-Chun Park; Eun Sun Jung; Sung Hak Lee; Sug Hyung Lee; Yeun-Jun Chung
Journal:  Oncotarget       Date:  2017-08-24
View more
  9 in total

1.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

2.  Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management.

Authors:  Kelly A Duffy; Christopher M Cielo; Jennifer L Cohen; Christina X Gonzalez-Gandolfi; Jessica R Griff; Evan R Hathaway; Jonida Kupa; Jesse A Taylor; Kathleen H Wang; Arupa Ganguly; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-08-30       Impact factor: 3.908

3.  The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Jessica R Griff; Riccardo Fagiano; Jonida Kupa; Garrett M Brodeur; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-04       Impact factor: 4.553

4.  11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.

Authors:  Elise M Fiala; Michael V Ortiz; Jennifer A Kennedy; Dominik Glodzik; Megan Harlan Fleischut; Kelly A Duffy; Evan R Hathaway; Todd Heaton; Justin T Gerstle; Peter Steinherz; Neerav Shukla; Nicole McNeer; Kaitlyn Tkachuk; Nancy Bouvier; Karen Cadoo; Maria I Carlo; Alicia Latham; Marianne Dubard Gault; Vijai Joseph; Yelena Kemel; Alex Kentsis; Zsofia Stadler; Michael La Quaglia; Elli Papaemmanuil; Danielle Friedman; Arupa Ganguly; Andrew Kung; Kenneth Offit; Jennifer M Kalish; Michael F Walsh
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

5.  Syndromic Disorders Caused by Disturbed Human Imprinting

Authors:  Diana Carli; Evelise Riberi; Giovanni Battista Ferrero; Alessandro Mussa
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-04-10

6.  Characteristics Associated with Tumor Development in Individuals Diagnosed with Beckwith-Wiedemann Spectrum: Novel Tumor-(epi)Genotype-Phenotype Associations in the BWSp Population.

Authors:  Kelly A Duffy; Kelly D Getz; Evan R Hathaway; Mallory E Byrne; Suzanne P MacFarland; Jennifer M Kalish
Journal:  Genes (Basel)       Date:  2021-11-21       Impact factor: 4.096

7.  Molecular networks of hepatoblastoma predisposition and oncogenesis in Beckwith-Wiedemann syndrome.

Authors:  Natali S Sobel Naveh; Emily M Traxler; Kelly A Duffy; Jennifer M Kalish
Journal:  Hepatol Commun       Date:  2022-05-04

Review 8.  Hepatoblastoma in molecularly defined, congenital diseases.

Authors:  Gunther Nussbaumer; Martin Benesch
Journal:  Am J Med Genet A       Date:  2022-04-28       Impact factor: 2.578

Review 9.  Lateralized and Segmental Overgrowth in Children.

Authors:  Alessandro Mussa; Diana Carli; Simona Cardaropoli; Giovanni Battista Ferrero; Nicoletta Resta
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.